2024 Summer Conference | C3 - Essential Immunology Principles for the (Autoimmune) Neurologist
Program Materials Program Evaluations
| 01:00 PM - 01:27 PM EDT | Speaker |
Targeting B-cells and Antibodies
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
| 01:27 PM - 01:54 PM EDT | Speaker |
T-cells: As Therapeutic Targets and Overzealous Attackers
Frank Leypoldt, MD |
| 01:54 PM - 02:21 PM EDT | Speaker |
Major Histocompatibility Complex Basics: What Is It, Why Do We Care?
Emmanuel Mignot, MD, PhD |
| 02:21 PM - 02:28 PM EDT | Abstract |
001 - Permissive Central Tolerance Plus Defective Peripheral Checkpoints License Pathogenic Memory B cells in CASPR2-Antibody Encephalitis
Anna L. Harrison |
| 02:28 PM - 02:35 PM EDT | Abstract |
027 - Peripherally Administered Therapeutic One-armed Antibody Reversed Behavioral Abnormalities in a Marmoset Model of Anti-NMDAR Encephalitis
Mitsuyuki Matsumoto, PhD |
| Avi Gadoth, MD | Dr. Gadoth has received intellectual property interests from a discovery or technology relating to health care. |
| Sudarshini Ramanathan, MBBS, PhD, FRACP | Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Alexion, Novartis. Dr. Ramanathan has received research support from NHMRC, RACP, University of Sydney. |
| Sarosh R. Irani, MD, PhD, FRCP, FEAN | Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
| Frank Leypoldt, MD | Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argen. The institution of Frank Leypoldt, MD has received research support from German Ministry of Research BMBF. |
| Emmanuel Mignot, MD, PhD | Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa . |
| Anna L. Harrison | Ms. Harrison has nothing to disclose. |
| Bo Sun, MBBS | Dr. Sun has nothing to disclose. |
| Anne-Kathrin Kienzler | Anne-Kathrin Kienzler has nothing to disclose. |
| Adam Handel | No disclosure on file |
| David Bennett, MD, PhD | Prof. Bennett has a non-compensated relationship as a Consultant with AditumBio that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with AstraZeneca that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Biogen that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Biointervene that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Combigene that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with LatigoBio that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with GSK that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Ionis that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Lexicon therapeutics that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Neuvati that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Novo Ventures 2023 that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consutlant with Olipass that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Orion that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Replay that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with SC Health Managers that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Third Rock ventures that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Vida Ventures that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received research funding with Lily that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received research funding with Astra Zeneca that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received an industrial partnership grant from AZ & the BBSRC with Astra Zeneca that is relevant to AAN interests or activities. |
| Simon J. Davis, PhD | Prof. Davis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MiroBio Ltd. Prof. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sidley Austin LLP. Prof. Davis has received research support from Wellcome Trust. Prof. Davis has received research support from Medical Research Council. Prof. Davis has received intellectual property interests from a discovery or technology relating to health care. |
| Michael R. Wilson, MD, FAAN | Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from UCSF Weill Institute for Neurosciences. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice. |
| Kevin O'Connor | Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Kevin O'Connor has stock in Cabaletta. |
| John N. Soltys, MD | Dr. Soltys has nothing to disclose. |
| Patrick Waters, PhD | Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care. |
| Meng Zhao | Dr. Zhao has nothing to disclose. |
| John Pluvinage, MD, PhD | Dr. Pluvinage has received research support from National Institute on Aging. |
| Ravi Dandekar | No disclosure on file |
| Bonny Alvarenga | No disclosure on file |
| Ray Owens | Ray Owens has received intellectual property interests from a discovery or technology relating to health care. |
| Daniel Anthony, PhD, MA | Dr. Anthony has received personal compensation for serving as an employee of University of Oxford. Dr. Anthony has received personal compensation for serving as an employee of Somerville College Oxford. Dr. Anthony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Anthony has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroplast. Dr. Anthony has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Oxomics. The institution of Dr. Anthony has received research support from Numares. The institution of Dr. Anthony has received research support from MRC UK. |
| Mateusz Makuch | No disclosure on file |
| Mitsuyuki Matsumoto, PhD | Dr. Matsumoto has received personal compensation for serving as an employee of Arialys Therapeutics, Inc.. Dr. Matsumoto has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Arialys Therapeutics, Inc.. Dr. Matsumoto has stock in Arialys Therapeutics, Inc.. Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care. |
| Masashi Maeda | No disclosure on file |
| Atsuo Kanno | No disclosure on file |
| Satoshi Kubo | No disclosure on file |
| Amir Razai | No disclosure on file |
| Shanni Yamaki | No disclosure on file |
| Roghiye Kazimi | No disclosure on file |
| Vallari Eastman | No disclosure on file |
| Mari Maurer | No disclosure on file |
| Mathew Mitchell | Mr. Mitchell has received personal compensation for serving as an employee of Arialys Therapeutics. |
| Jay Lichter, PhD | Dr. Lichter has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Janux. |
| Scott Snipas | No disclosure on file |